Medikit, a CBD-rich, superbly tasting and highly potent strain
You may have heard about Buddha Seeds for sure, a world-famous seed bank for the quality of its seeds. But probably you are not aware of its research efforts for the innovation and ongoing development of cannabis stains that do not stop surprising us.
Buddha Seeds, a Spanish company with more than 15 years of experience in the cannabis sector, focuses its efforts on genetic improvement to place and maintain their strains in the top market segments. Behind each strain is a hard work of selecting and stabilising desirable genetic traits, and exhaustive quality checks to ensure its final success, from germination to harvest. This work has gained the respect and loyalty of thousands of growers worldwide. Indeed, many varieties available on the market today originate from the early seeds of this bank. That is why, Buddha Seeds is now recognised at global level as a leading-edge seed bank.
Its multidisciplinary team includes engineers specialised in agronomy and biotechnology, who apply the most sophisticated technologies, such as a gas chromatography or genetic sequencing, to analyse plant genotypes and phenotypes. A specific methodology is used to characterise genes codifying enzymes responsible for the synthesis of cannabinoids. This methodology identifies the genomes of recently germinated seedlings to forecast their future cannabinoid profile in their adult state. This analysis is extremely advantageous for the genetic improvement programme that the bank breeders are carrying out, as it allows them to select the chemotype of parents and siblings without waiting until their flowering phase.
Despite their recent launch, Medikit and Medikit Auto have already met with great success among growers of CBD-rich varieties. The social network profiles of this Spanish brand are even showing images of crops grown in Switzerland, the cradle of the European CBD market, where the consumption and cultivation of CBD-rich strains are protected by national laws.
But Switzerland is not the only place where Medikit has grown in importance. In Latin American countries, such as Uruguay, this CBD plant will soon be available in cannabis clubs and associations. What is more, Buddha Seeds is continuing its expansion with this new CBD line and gaining new market shares in, e.g., the USA.
Medikit is a superior plant for its explosive growth, reaching more than four metres in height, if grown on a soil substrate outdoors, and produces abundant harvests. During flowering, Medikit is sublime, with bulky and compact flower bunches covered with an attractive crystalline resin coating.
Now that Medikit has made its flamboyant entry into the CBD market, what are you waiting for to taste it?
Buddha Seeds, a Spanish company with more than 15 years of experience in the cannabis sector, focuses its efforts on genetic improvement to place and maintain their strains in the top market segments. Behind each strain is a hard work of selecting and stabilising desirable genetic traits, and exhaustive quality checks to ensure its final success, from germination to harvest. This work has gained the respect and loyalty of thousands of growers worldwide. Indeed, many varieties available on the market today originate from the early seeds of this bank. That is why, Buddha Seeds is now recognised at global level as a leading-edge seed bank.
Its multidisciplinary team includes engineers specialised in agronomy and biotechnology, who apply the most sophisticated technologies, such as a gas chromatography or genetic sequencing, to analyse plant genotypes and phenotypes. A specific methodology is used to characterise genes codifying enzymes responsible for the synthesis of cannabinoids. This methodology identifies the genomes of recently germinated seedlings to forecast their future cannabinoid profile in their adult state. This analysis is extremely advantageous for the genetic improvement programme that the bank breeders are carrying out, as it allows them to select the chemotype of parents and siblings without waiting until their flowering phase.
Innovation at the service of quality
Buddha Seeds pride themselves with having probably the best research department in Europe. Cutting-edge techniques - such as selection assisted by molecular genetic markers; analysis of cannabinoids and terpenes by gas chromatography with a flame ionisation detector; in-vitro development, propagation and maintenance of genotypes, and identification and characterisation of polyploid individuals – are used to offer growers specimens with high vegetative vigour and a high level of cannabinoids. The Buddha Seeds team have a clear objective, i.e. to continue working to improve their market position among the leading seed banks. Their success formula is, quite simply, to place quality before quantity. Otherwise said, you will find fewer strains in their seed catalogue but all of them are highly reliable.Medikit conquered the CBD market
Unsurprisingly, 2018 was equally outstanding for the Buddha Seeds team. After years of research, they have devoted themselves headlong to the CBD market with the launch of Medikit and Medikit Auto, CBD-rich strains with a cannabidiol content of 20% or so and only 1% of THC. This plant has therefore valuable therapeutic and medical properties and is perfect for relaxing without psychoactive effect. Best of all, these qualities were obtained without affecting its aroma! Medikit stands out for its high CBD concentration and a high level of aromatic terpenes, which is quite unusual in these CBD varieties, whose taste is generally less pleasant. And now with Medikit, available on the market in both auto and non-auto versions, you will notice an improved taste, which is predominantly citric (orange, lemon or mango) with wooden and leather notes.
Despite their recent launch, Medikit and Medikit Auto have already met with great success among growers of CBD-rich varieties. The social network profiles of this Spanish brand are even showing images of crops grown in Switzerland, the cradle of the European CBD market, where the consumption and cultivation of CBD-rich strains are protected by national laws.
But Switzerland is not the only place where Medikit has grown in importance. In Latin American countries, such as Uruguay, this CBD plant will soon be available in cannabis clubs and associations. What is more, Buddha Seeds is continuing its expansion with this new CBD line and gaining new market shares in, e.g., the USA.
Medikit is a superior plant for its explosive growth, reaching more than four metres in height, if grown on a soil substrate outdoors, and produces abundant harvests. During flowering, Medikit is sublime, with bulky and compact flower bunches covered with an attractive crystalline resin coating.
Now that Medikit has made its flamboyant entry into the CBD market, what are you waiting for to taste it?
